If you’re comparing naltrexone vs. buprenorphine for opioid treatment, this post is written to give you a clear, honest picture.
How Each Medication Works
Buprenorphine is a partial opioid agonist, meaning it activates the same receptors in your brain that opioids do, but only partially. It reduces cravings and withdrawal symptoms without producing the same high. It’s most commonly prescribed as Suboxone, which combines buprenorphine with naloxone (a separate medication that prevents misuse). Other formulations include Subutex, Zubsolv, and the injectable Sublocade.
Naltrexone is a full opioid antagonist, meaning it completely blocks opioid receptors. It doesn’t activate them at all. This means it eliminates the rewarding effect of opioids entirely. It comes in a daily pill (Revia) or a once-monthly injectable (Vivitrol). Because it has no opioid activity, naltrexone carries no risk of physical dependence.
The core difference matters clinically: buprenorphine helps stabilize someone who is still physically dependent on opioids, while naltrexone requires that a person be fully detoxed before starting. Starting naltrexone too early will trigger severe withdrawal.
The Advantages and Disadvantages of Buprenorphine
Buprenorphine is typically the first-line recommendation for people who are currently physically dependent on opioids and want to start treatment right away. You don’t have to wait through a full detox period before it starts working. It reduces withdrawal symptoms within hours of the first dose, which lowers the barrier to getting started.
Advantages:
- Can be started quickly after last opioid use
- Reduces withdrawal and cravings effectively
- Long track record of safety and efficacy
- Available in multiple formulations including daily film/tablet or monthly injection (Sublocade)
- Can be prescribed via telehealth, which makes access significantly easier
Disadvantages:
- It is a controlled substance, meaning stricter prescribing regulations apply
- Some people prefer a medication with no opioid activity at all
- Requires ongoing prescriptions and check-ins
- Potential for misuse exists, though Suboxone’s naloxone component is designed to reduce this
At SkyCloud Health, we offer medication-assisted treatment for opioid use disorder in Oregon, Washington, and Utah, including buprenorphine-based treatment via both telehealth and in-person appointments. Our PMHNPs work closely with each patient to find the right dose and formulation.
The Advantages and Disadvantages of Naltrexone
Naltrexone is a good fit for people who have already completed detox and want a medication that carries no opioid activity whatsoever. Vivitrol, the monthly injectable form, is particularly appealing for people who want less daily decision-making around their medication. You get the injection once a month and don’t have to think about it every morning.
Advantages:
- No opioid activity, no physical dependence risk
- Once-monthly Vivitrol injection removes daily medication burden
- No controlled substance restrictions on prescribing
- Good option for people highly motivated to be fully abstinent
Disadvantages:
- Must be fully detoxed (typically 7–10 days opioid-free) before starting, or withdrawal is triggered
- Completing detox before naltrexone is a real barrier for many people, and research shows dropout rates during this waiting period are significant
- If a relapse occurs, opioid tolerance is dramatically reduced, increasing overdose risk
- Adherence to oral naltrexone (daily pills) is historically lower than to Vivitrol
Source: SciTechDaily
What the Research Actually Shows
The most frequently cited head-to-head comparison of these two medications is the X-BOT trial, published in The Lancet in 2018. Researchers randomized 570 people with OUD to receive either extended-release naltrexone (Vivitrol) or buprenorphine-naloxone (Suboxone). The headline finding: among people who actually started treatment, the two medications performed similarly in terms of opioid-free weeks and relapse rates.
The study found that 28% of participants assigned to the naltrexone group never made it to their first dose because they couldn’t complete detox first. Among those who did start, outcomes were comparable. That detox barrier is not a small footnote. It’s a real-world obstacle that tilts the population-level effectiveness toward buprenorphine, because buprenorphine gets more people into treatment in the first place.
Getting someone into treatment quickly, with the fewest barriers, is one of the strongest predictors of better outcomes.
How to Think About the Choice for Your Situation
The right medication depends on several factors your provider will assess with you. These include where you are in your use history right now, whether you’ve completed or can safely complete a detox period, your preferences around daily medication versus monthly injection, and whether you have co-occurring conditions like depression, anxiety, or PTSD that also need treatment.
If you are currently using opioids and want to start treatment now, buprenorphine is almost always the more accessible starting point. The detox requirement for naltrexone is not a character test. It’s just biology, and it’s a real barrier for many people in active use.
If you’ve already gone through detox, are motivated toward full abstinence, and want a medication with no opioid activity, naltrexone may be the stronger fit for you. The monthly Vivitrol shot in particular appeals to people who want to remove daily reminders of their treatment.
Co-occurring mental health conditions matter here too. Many people managing OUD are also dealing with trauma, depression, or anxiety. Our psychotherapy services are available alongside MAT for patients in Oregon, Washington, and Utah, because treating the whole person leads to better outcomes than medication alone. We also offer EMDR therapy for patients managing trauma alongside OUD, because these two things are frequently connected.
Neither medication is a sign of weakness. Both are evidence-based treatments that dramatically improve survival. The goal isn’t to find the “harder” path. It’s to find the path that actually works for you.
Source: Magnific
How SkyCloud Health Approaches MAT
Our clinical team includes Psychiatric Mental Health Nurse Practitioners who are experienced in opioid use disorder treatment and dual diagnosis care.
We take dual diagnosis seriously. If you’re managing OUD alongside another mental health condition, that’s not a complication that puts you out of reach of care. It’s exactly what our team is trained for.
If you’re ready to take the next step, you can reach us by calling (503) 967-2476 or booking directly online. You can also see what our clients say on Google if you want to get a sense of what care at SkyCloud actually feels like before you call.
Reviewed by Madeline Jacobs, PMHNP — Psychiatric Mental Health Nurse Practitioner, SkyCloud Mental Health
Madeline Jacobs, PMHNP, is a board-certified Psychiatric Mental Health Nurse Practitioner. She holds a Master of Science in Nursing from Oregon Health & Science University and has been working in the psychiatric field since 2015. She is trained in EMDR (eye movement desensitization and reprocessing) and specializes in anxiety, depression, and transgender-related mental health care. She takes a trauma-informed, LGBTQIA+-affirming approach.
